Unified Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$579K Sell
2,733
-50
-2% -$9.81K 0.53% 69
2026
Q1
$545K Sell
2,783
-269
-9% -$52.3K 0.56% 65
2025
Q4
$530K Sell
3,052
-12
-0.4% -$2.19K 0.53% 68
2025
Q3
$584K Sell
3,064
-101
-3% -$17.9K 0.58% 61
2025
Q2
$569K Buy
3,165
+52
+2% +$9.03K 0.61% 63
2025
Q1
$527K Sell
3,113
-557
-15% -$91.5K 0.62% 60
2024
Q4
$554K Buy
+3,670
New +$571K 0.63% 57

Other funds holding DGX

Unified Investment Management's DGX Position: Q2 2026 in Review

Unified Investment Management reduced its Quest Diagnostics (DGX) stake by 1.8% in Q2 2026, selling an estimated $9.81K and leaving 2,733 shares worth $579K. The position accounts for 0.53% of the portfolio, ranked #69.

Unified Investment Management first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $584K in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Unified Investment Management held 2,733 shares of Quest Diagnostics worth $579K as of Q2 2026.
  • Unified Investment Management sold 50 Quest Diagnostics shares in Q2 2026, an estimated $9.81K.
  • Quest Diagnostics made up 0.53% of Unified Investment Management's portfolio in Q2 2026, its #69 holding.
  • Unified Investment Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Unified Investment Management's Quest Diagnostics position peaked at $584K in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Unified Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.